21.5 C
New York
Saturday, June 3, 2023

Is Mereo BioPharma Group plc (NASDAQ: MREO) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Mereo BioPharma Group plc (MREO) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $1.13. The Mereo BioPharma Group plc has recorded 4,405 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.13 and fluctuated between $1.2000 as its day high and $1.0700 as its day low. The current market capitalization of Mereo BioPharma Group plc is $141.23M. A total of 3.07 million shares were traded on the day, compared to an average of 1.34M shares.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for MREO in the last 3 months, the mean price target is $4.25 with high estimates of $5.00 and low estimates of $4.00. In terms of 52-week highs and lows, MREO has a high of $1.85 and a low of $0.43.

As of this writing, MREO has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MREO’s latest balance sheet shows that the firm has $94.30M in Cash & Short Term Investments as of fiscal 2021. There were $16.76M in debt and $12.54M in liabilities at the time. Its Book Value Per Share was $0.50, while its Total Shareholder’s Equity was $88.00M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MREO is Buy with a score of 4.67.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles